Latest scientific publications

Angiotensin-(1-7) infusion in COVID-19 patients admitted to the ICU: a seamless phase 1-2 randomized clinical trial.

Martins ALV, Annoni F, da Silva FA, Bolais-Ramos L, de Oliveira GC, Ribeiro RC, Diniz MML, Silva TGF, Pinheiro BD, Rodrigues NA, Dos Santos Matos AH, Motta-Santos D, Campagnole-Santos MJ, Verano-Braga T, Taccone FS, Santos RAS

Angiotensin-(1-7) infusion in COVID-19 patients admitted to the ICU: a seamless phase 1-2 randomized clinical trial.

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.

Fontana M, Berk JL, Gillmore JD, Witteles RM, Grogan M, Drachman B, Damy T, Garcia-Pavia P, Taubel J, Solomon SD, Sheikh FH, Tahara N, González-Costello J, Tsujita K, Morbach C, Pozsonyi Z, Petrie MC, Delgado D, Van der Meer P, Jabbour A, Bondue A, Kim D, Azevedo O, Hvitfeldt Poulsen S, Yilmaz A, Jankowska EA, Algalarrondo V, Slugg A, Garg PP, Boyle KL, Yureneva E, Silliman N, Yang L, Chen J, Eraly SA, Vest J, Maurer MS

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.

Fontana M, Berk JL, Gillmore JD, Witteles RM, Grogan M, Drachman B, Damy T, Garcia-Pavia P, Taubel J, Solomon SD, Sheikh FH, Tahara N, González-Costello J, Tsujita K, Morbach C, Pozsonyi Z, Petrie MC, Delgado D, Van der Meer P, Jabbour A, Bondue A, Kim D, Azevedo O, Hvitfeldt Poulsen S, Yilmaz A, Jankowska EA, Algalarrondo V, Slugg A, Garg PP, Boyle KL, Yureneva E, Silliman N, Yang L, Chen J, Eraly SA, Vest J, Maurer MS

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

Hoyois A, Gulkilik C, Mekkaoui L, Dahma H, Wambacq V, Minsart C, Rosewick N, Liefferinckx C, Amininejad L, Van Gossum A, Cremer A, Vandenberg O, Franchimont D

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

Hoyois A, Gulkilik C, Mekkaoui L, Dahma H, Wambacq V, Minsart C, Rosewick N, Liefferinckx C, Amininejad L, Van Gossum A, Cremer A, Vandenberg O, Franchimont D

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

Hoyois A, Gulkilik C, Mekkaoui L, Dahma H, Wambacq V, Minsart C, Rosewick N, Liefferinckx C, Amininejad L, Van Gossum A, Cremer A, Vandenberg O, Franchimont D

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

Hoyois A, Gulkilik C, Mekkaoui L, Dahma H, Wambacq V, Minsart C, Rosewick N, Liefferinckx C, Amininejad L, Van Gossum A, Cremer A, Vandenberg O, Franchimont D

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

Hoyois A, Gulkilik C, Mekkaoui L, Dahma H, Wambacq V, Minsart C, Rosewick N, Liefferinckx C, Amininejad L, Van Gossum A, Cremer A, Vandenberg O, Franchimont D

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

Hoyois A, Gulkilik C, Mekkaoui L, Dahma H, Wambacq V, Minsart C, Rosewick N, Liefferinckx C, Amininejad L, Van Gossum A, Cremer A, Vandenberg O, Franchimont D

SARS-CoV-2 antibody vaccine response in Inflammatory Bowel Disease patients with positive anti-nucleocapsid serology or history of COVID-19 infection.

Bordet hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications

Scientific publications by Jules Bordet

Erasme hospital

Erasmus Hospital

View all of Erasmus's scientific publications

Erasmus's academic publications

Huderf hospital

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital

Scientific publications from the Queen Fabiola Children's Hospital